Discover
RARE
Ultragenyx Pharmaceutical Inc.
32.38
2 x 23.58
2 x 41.51
bid
ask
-
1.01
3.02%
2 @ 04:00 PM
32.38 +0.00 (0.00%)
| Ytd | 40.78% | |
| 1y | -10.70% |
32.34
day range
33.49
18.29
52 week range
42.37
| Open | 33.13 | Prev Close | 33.39 | Low | 32.34 | High | 33.49 | Mkt Cap | 3.19B |
| Vol | 2.31M | Avg Vol | 2.12M | EPS | -6.10 | P/E | N/A | Forward P/E | 33.55 |
| Beta | 0.38 | Short Ratio | 9.06 | Inst. Own | 104.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 25.29 | 200-d Avg | 27.00 | 1yr Est | 52.05 |
| Income Statement | |||
| Total Revenue | 136.00M | ||
| Revenues (USD) | 136.00M | ||
| Cost of Revenue | 30.00M | ||
| Gross Profit | 106.00M | ||
| Operating Expenses | 275.00M | ||
| Research and Development Expense | 187.00M | ||
| Selling, General and Administrative Expense | 88.00M | ||
| Operating Income | -169.00M | ||
| Income Tax Expense | 1000.00K | ||
| Net Income | -185.00M | ||
| Net Income Common Stock | -185.00M | ||
| Net Income Common Stock (USD) | -185.00M | ||
| Consolidated Income | -185.00M | ||
| Earnings per Basic Share | -1.84 | ||
| Earnings per Basic Share (USD) | -1.84 | ||
| Earnings per Diluted Share | -1.84 | ||
| Earning Before Interest & Taxes (EBIT) | -184.00M | ||
| Earning Before Interest & Taxes (USD) | -184.00M | ||
| Weighted Average Shares | 100.60M | ||
| Weighted Average Shares Diluted | 100.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 175.00M | ||
| Cash and Equivalents (USD) | 175.00M | ||
| Investments | 359.00M | ||
| Investments Current | 238.00M | ||
| Investments Non-Current | 121.00M | ||
| Trade and Non-Trade Receivables | 121.00M | ||
| Current Assets | 657.00M | ||
| Property, Plant & Equipment Net | 239.00M | ||
| Total Assets | 1.30B | ||
| Debt Current | 72.00M | ||
| Total Debt | 1.20B | ||
| Current Liabilities | 325.00M | ||
| Debt Non-Current | 1.13B | ||
| Total Liabilities | 1.53B | ||
| Accumulated Retained Earnings (Deficit) | -4.72B | ||
| Shareholders Equity | -243.00M | ||
| Shareholders Equity (USD) | -243.00M | ||
| Assets Non-Current | 639.00M | ||
| Total Debt (USD) | 1.20B | ||
| Goodwill and Intangible Assets | 218.00M | ||
| Inventory | 55.00M | ||
| Liabilities Non-Current | 1.20B | ||
| Trade and Non-Trade Payables | 42.00M | ||
| Tax Liabilities | 30.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 8.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -247.00M | ||
| Capital Expenditure | -1000.00K | ||
| Net Cash Flow from Investing | -49.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -43.00M | ||
| Net Cash Flow from Operations | -197.00M | ||
| Effect of Exchange Rate Changes on Cash | -1000.00K | ||
| Share Based Compensation | 30.00M | ||